London-based oncology drug developer, Ellipses Pharma, is exploring a potential Main Market listing through a proposed reverse takeover of Wolfram Resources, with completion targeted for early 2027
For most employees, pension saving happens in the background. Contributions are paid in each month, but few people make an active investment choice.